Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group studyGini F. Fleming, James V. Fiorica, Julia Chapman et al.|Gynecologic Oncology|2009Cited by 297